Fresenius Medical Care AG & Co. KGaA is a kidney dialysis company. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD), as well as other healthcare services. The Company's segments include North America Segment, the Europe, Middle East and Africa (EMEA) Segment, the Asia-Pacific Segment and the Latin America Segment. The Company develops and manufactures a range of dialysis machines, systems and disposable products. As of December 31, 2016, the Company sold its products to customers in more than 120 countries and also used in its internal healthcare service operations. The Company's Care Coordination services include coordinated delivery of pharmacy services, vascular, cardiovascular and endovascular specialty services, non-dialysis laboratory testing services, physician services, hospitalist and intensivist services, health plan services, ambulatory surgery center services and urgent care services.
Industry, Sector and Symbol:
- Sector: Medical
- Industry: Healthcare Facilities & Services
- Sub-Industry: N/A
- Symbol: NYSE:FMS
- CUSIP: N/A
- Web: www.fmc-ag.com
Capitalization:- Market Cap: $30.46592 billion
- Outstanding Shares: 613,722,000
Average Prices:- 50 Day Moving Avg: $47.05
- 200 Day Moving Avg: $46.00
- 52 Week Range: $38.05 - $50.22
P/E:- Trailing P/E Ratio: 21.15
- Foreward P/E Ratio: 18.51
- P/E Growth: 2.05
Sales & Book Value:- Annual Revenue: $20.52 billion
- Price / Sales: 1.47
- Book Value: $18.83 per share
- Price / Book: 2.60
Dividend:- Annual Dividend: $0.37
- Dividend Yield: 0.8%
Profitability:- EBIDTA: $3.75 billion
- Net Margins: 7.06%
- Return on Equity: 11.57%
- Return on Assets: 4.97%
Debt:- Debt-to-Equity Ratio: 0.60%
- Current Ratio: 1.27%
- Quick Ratio: 1.03%
Misc:- Average Volume: 165,931 shs.
- Beta: 0.48
- Short Ratio: 6.94
Frequently Asked Questions for Fresenius Medical Care Corporation (NYSE:FMS)
What is Fresenius Medical Care Corporation's stock symbol?
Fresenius Medical Care Corporation trades on the New York Stock Exchange (NYSE) under the ticker symbol "FMS."
How often does Fresenius Medical Care Corporation pay dividends? What is the dividend yield for Fresenius Medical Care Corporation?
Fresenius Medical Care Corporation declared an annual dividend on Monday, April 24th. Stockholders of record on Monday, May 15th will be given a dividend of $0.5137 per share on Friday, May 26th. This represents a dividend yield of 1.17%. The ex-dividend date of this dividend is Thursday, May 11th. View Fresenius Medical Care Corporation's Dividend History.
How were Fresenius Medical Care Corporation's earnings last quarter?
Fresenius Medical Care Corporation (NYSE:FMS) released its quarterly earnings results on Tuesday, August, 1st. The company reported $0.48 earnings per share for the quarter, missing the Zacks' consensus estimate of $0.53 by $0.05. The business had revenue of $4.47 billion for the quarter, compared to the consensus estimate of $5.20 billion. Fresenius Medical Care Corporation had a net margin of 7.06% and a return on equity of 11.57%. The business's quarterly revenue was up 11.1% on a year-over-year basis. During the same quarter in the prior year, the company posted $0.96 EPS. View Fresenius Medical Care Corporation's Earnings History.
When will Fresenius Medical Care Corporation make its next earnings announcement?
Where is Fresenius Medical Care Corporation's stock going? Where will Fresenius Medical Care Corporation's stock price be in 2017?
10 brokerages have issued 1-year target prices for Fresenius Medical Care Corporation's stock. Their forecasts range from $44.00 to $48.00. On average, they expect Fresenius Medical Care Corporation's stock price to reach $46.00 in the next year. View Analyst Ratings for Fresenius Medical Care Corporation.
Who are some of Fresenius Medical Care Corporation's key competitors?
Some companies that are related to Fresenius Medical Care Corporation include HCA Holdings (HCA), Laboratory Corporation of America Holdings (LH), Quest Diagnostics Incorporated (DGX), DaVita HealthCare Partners (DVA), Universal Health Services (UHS), NMC Health PLC (NMC), HealthSouth Corporation (HLS), Acadia Healthcare Company (ACHC), Mednax (MD), Molina Healthcare (MOH), Chemed Corp. (CHE), Select Medical Holdings Corporation (SEM), LifePoint Health (LPNT), Udg Healthcare PLC (UDG), HMS Holdings Corp (HMSY), Tenet Healthcare Corporation (THC), China Cord Blood Corporation (CO) and Community Health Systems (CYH).
Who are Fresenius Medical Care Corporation's key executives?
Fresenius Medical Care Corporation's management team includes the folowing people:
- Gerd Krick, Chairman of the Supervisory Board
- Rice Powell, Chairman of the Management Board, Chief Executive Officer
- Dieter Schenk, Vice Chairman of the Supervisory Board
- Michael Brosnan, Chief Financial Officer, Member of the Management Board
- Harry De Wit, Chief Executive Officer for Asia-Pacific, Member of the Management Board
- Olaf Schermeier, Chief Executive Officer for Global Research and Development, Member of the Management Board
- William Valle, Chief Executive Officer for North America, Member of the Management Board
- Kent Wanzek, Chief Executive Officer for Global Manufacturing & Quality, Member of the Management Board
- Dominik Wehner, Chief Executive Officer for Europe, Middle East and Africa (EMEA), Member of the Management Board
- Ben J. Lipps, Honorary Chairman
Who owns Fresenius Medical Care Corporation stock?
Fresenius Medical Care Corporation's stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include Harding Loevner LP (0.61%), Cambiar Investors LLC (0.42%), Northern Trust Corp (0.15%), Marathon Asset Management LLP (0.10%), Royal Bank of Canada (0.08%) and US Bancorp DE (0.07%). View Institutional Ownership Trends for Fresenius Medical Care Corporation.
Who sold Fresenius Medical Care Corporation stock? Who is selling Fresenius Medical Care Corporation stock?
Fresenius Medical Care Corporation's stock was sold by a variety of institutional investors in the last quarter, including Manning & Napier Advisors LLC, Boston Partners, Wells Fargo & Company MN, JPMorgan Chase & Co., William Blair Investment Management LLC, Citadel Advisors LLC, People s United Financial Inc. and Northern Trust Corp. View Insider Buying and Selling for Fresenius Medical Care Corporation.
Who bought Fresenius Medical Care Corporation stock? Who is buying Fresenius Medical Care Corporation stock?
Fresenius Medical Care Corporation's stock was purchased by a variety of institutional investors in the last quarter, including Harding Loevner LP, Cambiar Investors LLC, Harbour Capital Advisors LLC, OxFORD Asset Management LLP, Ativo Capital Management LLC, US Bancorp DE, Kayne Anderson Rudnick Investment Management LLC and Parametric Portfolio Associates LLC. View Insider Buying and Selling for Fresenius Medical Care Corporation.
How do I buy Fresenius Medical Care Corporation stock?
Shares of Fresenius Medical Care Corporation can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Fresenius Medical Care Corporation's stock price today?
One share of Fresenius Medical Care Corporation stock can currently be purchased for approximately $49.05.
MarketBeat Community Rating for Fresenius Medical Care Corporation (NYSE FMS)MarketBeat's community ratings are surveys of what our community members think about Fresenius Medical Care Corporation and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Consensus Ratings for Fresenius Medical Care Corporation (NYSE:FMS) (How are Consensus Ratings Calculated?) MarketBeat calculates consensus ratings using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings. Each stock's consensus rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
| Ratings Breakdown: | 3 Hold Ratings, 7 Buy Ratings |
| Consensus Rating: | Buy (Score: 2.70) |
| Consensus Price Target: | $46.00 (6.22% downside) |
Analysts' Ratings History for Fresenius Medical Care Corporation (NYSE:FMS)
Show:
| Date | Firm | Action | Rating | Price Target | Impact on Share Price | Details |
|---|
| 9/13/2017 | Royal Bank Of Canada | Reiterated Rating | Hold | $44.00 | Low |  |
| 8/7/2017 | DZ Bank AG | Reiterated Rating | Buy | | Medium | |
| 6/28/2017 | Nord/LB | Reiterated Rating | Buy | | Low | |
| 3/12/2017 | Sanford C. Bernstein | Reiterated Rating | Buy | | Low | |
| 2/24/2017 | Societe Generale | Downgrade | Buy -> Hold | | N/A | |
| 12/14/2016 | J P Morgan Chase & Co | Reiterated Rating | Buy | | N/A | |
| 10/18/2016 | HSBC Holdings plc | Reiterated Rating | Hold | | N/A | |
| 10/18/2016 | Citigroup Inc. | Reiterated Rating | Buy | | N/A | |
| 10/13/2016 | SunTrust Banks, Inc. | Set Price Target | Buy | $48.00 | N/A | |
| 9/21/2016 | Goldman Sachs Group, Inc. (The) | Reiterated Rating | Buy | | N/A | |
| 8/9/2016 | Berenberg Bank | Reiterated Rating | Buy | | N/A | |
| 7/8/2016 | Jefferies Group LLC | Upgrade | Underperform -> Hold | | N/A | |
| 5/16/2016 | Robert W. Baird | Reiterated Rating | Hold | | N/A | |
| 3/17/2016 | Nomura | Initiated Coverage | Buy | | N/A | |
| 11/9/2015 | Barclays PLC | Downgrade | Equal Weight -> Underweight | | N/A | |
| 10/30/2015 | Piper Jaffray Companies | Reiterated Rating | Hold | $41.00 -> $43.00 | N/A | |
(Data available from 9/21/2015 forward)
Earnings History for Fresenius Medical Care Corporation (NYSE:FMS)Earnings History by Quarter for Fresenius Medical Care Corporation (NYSE FMS)| Date | Quarter | Consensus Estimate | Actual EPS | Revenue Estimate | Actual Revenue | Release Link | Conference Call | Details |
|---|
| 10/26/2017 | | | | | | | | |
| 8/1/2017 | 6/30/2017 | $0.53 | $0.48 | $5.20 billion | $4.47 billion | View | Listen | |
| 5/3/2017 | Q2 | $0.44 | $0.53 | $4.69 billion | $4.55 billion | View | Listen | |
| 2/22/2017 | Q416 | $0.62 | $0.63 | $4.74 billion | $4.69 billion | View | Listen | |
| 10/27/2016 | Q316 | $0.52 | $0.54 | $4.55 billion | $4.60 billion | View | Listen | |
| 8/1/2016 | Q216 | $0.49 | $0.48 | $4.54 billion | $4.42 billion | View | N/A | |
| 5/3/2016 | Q116 | $0.42 | $0.37 | $4.25 billion | $4.21 billion | View | N/A | |
| 2/24/2016 | Q415 | $0.58 | $0.52 | $4.41 million | $4.35 million | View | Listen | |
| 10/29/2015 | Q3 | $0.45 | $0.43 | $4.27 billion | $4.23 billion | View | Listen | |
| 7/30/2015 | Q215 | $0.42 | $0.40 | $4.13 billion | $4.20 billion | View | Listen | |
| 4/30/2015 | Q1 | $0.40 | $0.35 | $3.89 billion | $3.96 billion | View | N/A | |
| 2/25/2015 | Q4 | $0.49 | $0.56 | $4.23 billion | $4.32 billion | View | N/A | |
| 11/4/2014 | Q3 | $0.44 | $0.45 | $3.94 billion | $4.11 billion | View | N/A | |
| 7/31/2014 | Q2 | $0.41 | $0.39 | | $3.84 billion | View | N/A | |
| 5/6/2014 | Q1 2014 | $0.38 | $0.34 | $3.60 billion | $3.56 billion | View | N/A | |
| 2/25/2014 | Q4 | $0.53 | $0.58 | | | View | N/A | |
| 11/5/2013 | | $0.45 | $0.47 | | | View | N/A | |
| 7/30/2013 | | $0.46 | $0.43 | | | View | N/A | |
(Data available from 1/1/2011 forward)
Earnings Estimates for Fresenius Medical Care Corporation (NYSE:FMS)2017 EPS Consensus Estimate: $2.11
2018 EPS Consensus Estimate: $2.58
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|
| Q1 2017 | 1 | $0.44 | $0.44 | $0.44 |
| Q2 2017 | 1 | $0.54 | $0.54 | $0.54 |
| Q3 2017 | 1 | $0.56 | $0.56 | $0.56 |
| Q4 2017 | 1 | $0.57 | $0.57 | $0.57 |
| Q1 2018 | 1 | $0.61 | $0.61 | $0.61 |
| Q2 2018 | 1 | $0.64 | $0.64 | $0.64 |
| Q3 2018 | 1 | $0.66 | $0.66 | $0.66 |
| Q4 2018 | 1 | $0.67 | $0.67 | $0.67 |
| Q1 2019 | 1 | $0.67 | $0.67 | $0.67 |
| Q2 2019 | 1 | $0.68 | $0.68 | $0.68 |
(Data provided by Zacks Investment Research)
Current Dividend Information for Fresenius Medical Care Corporation (NYSE:FMS)| Most Recent Dividend: | 5/26/2017 |
| Annual Dividend: | $0.37 |
| Dividend Yield: | 0.75% |
| Dividend Growth: | -2.10% (3 Year Average) |
| Payout Ratio: | 16.97% (Trailing 12 Months of Earnings)
15.48% (Based on This Year's Estimates)
13.96% (Based on Next Year's Estimates)
|
Dividend History by Quarter for Fresenius Medical Care Corporation (NYSE FMS)| Announced | Period | Amount | Yield | Ex-Dividend Date | Record Date | Payable Date |
|---|
| 4/24/2017 | annual | $0.51 | 1.17% | 5/11/2017 | 5/15/2017 | 5/26/2017 |
| 3/9/2016 | | $0.30 | | 5/10/2016 | 5/12/2016 | 5/23/2016 |
| 5/2/2014 | annual | $0.53 | 1.57% | 5/13/2014 | 5/15/2014 | 5/27/2014 |
| 5/14/2013 | annual | $0.49 | 1.42% | 5/14/2013 | 5/16/2013 | 5/28/2013 |
(Data available from 1/1/2013 forward)
Insider Trading History for Fresenius Medical Care Corporation (NYSE:FMS)
No insider trades for this company have been tracked by MarketBeat.com
Headline Trends for Fresenius Medical Care Corporation (NYSE:FMS)
Latest Headlines for Fresenius Medical Care Corporation (NYSE:FMS)
| Source: |
|
| Date | Headline |
|---|
 | Quest Diagnostics (DGX) versus Fresenius Medical Care Corporation (FMS) Head-To-Head Comparison
www.americanbankingnews.com - September 18 at 6:23 PM |
| Fresenius Medical Care Corporation to Post Q1 2019 Earnings of $0.67 Per Share, SunTrust Banks Forecasts (FMS)
www.americanbankingnews.com - September 18 at 8:00 AM |
 | Fresenius Medical Care North America Announces Scholarship Program for Nurses of the American Nephrology Nurses Association
finance.yahoo.com - September 15 at 7:16 PM |
| Analyzing Quest Diagnostics (DGX) and Fresenius Medical Care Corporation (FMS)
www.americanbankingnews.com - September 15 at 6:29 PM |
| Fresenius Medical Care Corporation's (FMS) "Hold" Rating Reiterated at Royal Bank Of Canada
www.americanbankingnews.com - September 13 at 9:44 PM |
| Like Mother Like Daughter
finance.yahoo.com - September 13 at 8:12 PM |
| Fresenius Medical Care Corporation (FMS) Given Consensus Rating of "Hold" by Brokerages
www.americanbankingnews.com - September 12 at 9:02 PM |
| Head to Head Comparison: Fresenius Medical Care Corporation (FMS) and its Competitors
www.americanbankingnews.com - September 11 at 6:20 AM |
| Financial Survey: Fresenius Medical Care AG & Co. (FMS) and its Competitors
www.americanbankingnews.com - September 10 at 12:24 AM |
 | Fresenius Medical Care (FMS) Presents At 2017 Wells Fargo Healthcare Conference - Slideshow
seekingalpha.com - September 7 at 6:52 PM |
 | Universal Health Services, Inc. (UHS) Ex-Dividend Date Scheduled for August 30 ...
www.nasdaq.com - August 30 at 12:14 AM |
| Fresenius Medical Care Corporation (FMS) versus Mednax (MD) Financial Contrast
www.americanbankingnews.com - August 25 at 8:56 AM |
| Fresenius Medical Care Corporation (FMS) Receives Consensus Recommendation of "Hold" from Brokerages
www.americanbankingnews.com - August 18 at 8:56 PM |
| EMEA and APAC: Fresenius Medical Care’s Dialysis Products Business
finance.yahoo.com - August 18 at 6:36 PM |
| Fresenius Medical Care Is a Global Leader in the Dialysis Segment
finance.yahoo.com - August 18 at 6:36 PM |
| Short Interest in Fresenius Medical Care Corporation (FMS) Declines By 42.0%
www.americanbankingnews.com - August 17 at 3:44 AM |
| Fresenius Medical Care Corporation (FMS) Downgraded by Zacks Investment Research to Hold
www.americanbankingnews.com - August 16 at 3:48 PM |
| $5.13 Billion in Sales Expected for Fresenius Medical Care Corporation (FMS) This Quarter
www.americanbankingnews.com - August 14 at 9:52 AM |
| $0.58 Earnings Per Share Expected for Fresenius Medical Care Corporation (NYSE:FMS) This Quarter
www.americanbankingnews.com - August 12 at 6:12 AM |
| NxStage (NXTM) Jumps 28% on $2 Billion Acquisition by FMS
finance.yahoo.com - August 9 at 11:58 PM |
| Corporate News Blog - Fresenius Medical Care to Acquire NxStage Medical to Strengthen Its Vertically Integrated Dialysis Business
finance.yahoo.com - August 9 at 6:57 PM |
| NxStage Medical Acquired by Fresenius for $2 Billion
finance.yahoo.com - August 7 at 9:13 PM |
| [$$] Fresenius Medical Care agrees $2bn deal to buy NxStage
finance.yahoo.com - August 7 at 9:13 PM |
| NxStage (NXTM) Jumps 28% on $2 Billion Acquisition by FMS
finance.yahoo.com - August 7 at 9:13 PM |
| Fresenius Medical Care AG & Co. KGaA :FMS-US: Earnings Analysis: Q2, 2017 By the Numbers : August 7, 2017
finance.yahoo.com - August 7 at 9:13 PM |
| Buyout Bid Overshadows NxStage Medical's Losses
finance.yahoo.com - August 7 at 9:13 PM |
 | Fresenius Medical Care (FMS) to Acquire NxStage Medical (NXTM) for $30/Sh; Transaction Valued at $2B
www.streetinsider.com - August 7 at 4:13 PM |
| Fresenius Medical Care Corporation (NYSE:FMS) Stock Rating Reaffirmed by DZ Bank AG
www.americanbankingnews.com - August 7 at 11:46 AM |
 | Fresenius Medical Care To Buy NxStage Medical In $2 Bln Deal - Quick Facts
www.rttnews.com - August 7 at 3:37 AM |
| Germany's FMC to buy U.S. home dialysis firm NxStage for $2 bln
finance.yahoo.com - August 7 at 3:37 AM |
| Fresenius Medical Care to Acquire NxStage Medical, Inc. to Strengthen Its Vertically Integrated Dialysis Business
finance.yahoo.com - August 7 at 3:37 AM |
| Jefferies Group Weighs in on Fresenius Medical Care Corporation's FY2017 Earnings (FMS)
www.americanbankingnews.com - August 4 at 11:10 AM |
| SunTrust Banks Equities Analysts Increase Earnings Estimates for Fresenius Medical Care Corporation (NYSE:FMS)
www.americanbankingnews.com - August 4 at 11:08 AM |
| Fresenius Medical Care Enters Oversold Territory
www.nasdaq.com - August 2 at 7:35 PM |
| Fresenius Medical Care Corporation (FMS) Announces Quarterly Earnings Results
www.americanbankingnews.com - August 2 at 7:06 PM |
| Fresenius Medical Care AG & Co. KGaA (FMS) Q2 2017 Results - Earnings Call Transcript
seekingalpha.com - August 1 at 7:20 PM |
| Fresenius Medical Care Corporation's (FMS) Neutral Rating Reaffirmed at Royal Bank Of Canada
www.americanbankingnews.com - August 1 at 12:56 PM |
| Fresenius Medical Care Q2 EBIT Rises; Confirms 2017 Outlook
www.rttnews.com - August 1 at 4:30 AM |
| Fresenius Medical Care Corporation (FMS) to Release Quarterly Earnings on Tuesday
www.americanbankingnews.com - July 27 at 11:12 AM |
| Fresenius Medical Care Corporation (NYSE:FMS) Expected to Announce Quarterly Sales of $4.79 Billion
www.americanbankingnews.com - July 26 at 10:40 AM |
| $0.53 Earnings Per Share Expected for Fresenius Medical Care Corporation (FMS) This Quarter
www.americanbankingnews.com - July 25 at 12:26 AM |
| Fresenius Medical Care Corporation (FMS) Given Average Recommendation of "Buy" by Brokerages
www.americanbankingnews.com - July 24 at 9:04 PM |
 | Fresenius Medical Care North America Receives Safety In Excellence Award From ...
www.prnewswire.com - July 19 at 7:25 PM |
| Fresenius Medical Care Refinances Existing Senior Secure Credit Deal
www.nasdaq.com - July 12 at 7:28 PM |
| William McKinney, Fresenius Medical Care North America, Named Chair of Austin Kidney Walk
finance.yahoo.com - July 12 at 7:28 PM |
| ETFs with exposure to Fresenius Medical Care AG & Co. KGaA : July 12, 2017
finance.yahoo.com - July 12 at 7:28 PM |
| Fresenius Medical Care Holdings, Inc. -- Moody's upgrades FMCH's long term issuer rating to Baa3, outlook stable
finance.yahoo.com - July 8 at 10:50 AM |
| Fresenius Medical Care Corporation (NYSE:FMS) Stock Rating Reaffirmed by Royal Bank Of Canada
www.americanbankingnews.com - July 5 at 9:20 PM |
| Fresenius Medical Care Corporation (NYSE:FMS) Rating Reiterated by Nord/LB
www.americanbankingnews.com - July 2 at 1:56 PM |
| Zacks: Analysts Anticipate Fresenius Medical Care Corporation (FMS) Will Post Quarterly Sales of $4.79 Billion
www.americanbankingnews.com - June 30 at 11:56 AM |
Fresenius Medical Care Corporation (FMS) Chart for Thursday, September, 21, 2017
